Last update 21 Jul 2025

Navlimetostat

Overview

Basic Info

Drug Type
Non-degrading molecular glue
Synonyms
BMS-986504, MRTX 1719, MRTX-1719
+ [1]
Target
Action
inhibitors
Mechanism
MTA-PRMT5 inhibitors(MTA-Cooperative PRMT5 inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2/3
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC23H18ClFN6O2
InChIKeyBZKIOORWZAXIBA-UHFFFAOYSA-N
CAS Registry2629314-96-9

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
United States
03 Nov 2025
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
China
03 Nov 2025
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
Japan
03 Nov 2025
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
Argentina
03 Nov 2025
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
Australia
03 Nov 2025
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
Austria
03 Nov 2025
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
Belgium
03 Nov 2025
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
Brazil
03 Nov 2025
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
Canada
03 Nov 2025
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
Chile
03 Nov 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
152
rypvjupype(zooqyovaug) = djdlsomolg tafazevduh (nztpplnggn )
Positive
30 May 2025
Phase 1/2
63
byojbehclr(vitxvzvczt) = zjxapoprco lkbxxpvtpq (gonqowlnat )
Positive
28 Apr 2025
byojbehclr(vitxvzvczt) = sxxvnqrblg lkbxxpvtpq (gonqowlnat )
Phase 1/2
125
qusowvbesw(xckenavhzh) = dcbzougtaj bwenayfpzo (zvepfikuun )
Positive
24 Oct 2024
(NSCLC)
qusowvbesw(xckenavhzh) = ldzkjjwwbh bwenayfpzo (zvepfikuun )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free